Absci ABSI
NASDAQ ABSI
$8.84 +0.03 (+0.40%)
As of: Sep 4, 2026 · 2:21 PM EDT

Absci (ABSI) Receivables (2020 - 2026)

Absci (ABSI) posted Receivables of $100000.0 for Q1 2026, down 90.0% sequentially from $1.0 million in Q3 2025, and down 92.77% YoY from $1.4 million in Q1 2025.

Analysis

Absci (ABSI) Receivables (2020 - 2026) Analysis & Trends

Absci has reported Receivables for 7 years, with the latest figure at $100000.0 in Q1 2026.

  • Quarterly Receivables fell 92.77% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (down 92.77% YoY) and the FY2023 annual result came in at $2.2 million, up 41.23% from the prior year.
  • Receivables slipped to $100000.0 in Q1 2026 per ABSI's latest filing, from $1.0 million in the prior quarter.
  • Over five years, Receivables peaked at $3.2 million in Q2 2023 and troughed at $42000.0 in Q1 2024.
  • A 5-year average of $947466.7 and a median of $800000.0 in 2023 frame the typical range for Receivables.
  • The sharpest annual moves came in 2024 and 2025: Receivables tumbled 98.61% in 2024, then jumped 3195.24% in 2025.
  • Over 5 years, Receivables stood at $1.1 million in 2022, then soared by 99.0% to $2.2 million in 2023, then plunged by 31.48% to $1.5 million in 2024, then plunged by 33.33% to $1.0 million in 2025, then sank by 90.0% to $100000.0 in 2026.
  • According to Business Quant data, Receivables over the past three periods registered $100000.0, $1.0 million, and $700000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 2.13 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 6.57 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 1.93 Bn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 160.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 1.06 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 912.74 Mn
8 Royalty Pharma 28.42 Bn 27.59 Bn - -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 215.33 Mn
10 Absci 1.40 Bn 1.19 Bn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 100,000.00
Sep 30, 2025 16.00 Mn
Jun 30, 2025 15.70 Mn
Mar 31, 2025 16.38 Mn
Dec 31, 2024 15.00 Mn
Sep 30, 2024 16.50 Mn
Jun 30, 2024 15.04 Mn
Mar 31, 2024 15.04 Mn
Dec 31, 2023 17.19 Mn
Sep 30, 2023 15.80 Mn
Jun 30, 2023 18.16 Mn
Mar 31, 2023 16.33 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 210,000.00
Jun 30, 2022 310,000.00
Mar 31, 2022 350,000.00
Dec 31, 2021 600,000.00
Sep 30, 2021 714,000.00
Jun 30, 2021 545,000.00